EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 3.0

Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis

Yuxiao Chen, Jie Sun, Zhen Yang, Hongyan Bi

Advances in Clinical and Experimental Medicine · 2023

DOI: 10.17219/acem/161159 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Yuxiao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Psychotic Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesPsychotic DisordersHumansSerotoninActivities of Daily LivingDrug Inverse AgonismReceptor, Serotonin, 5-HT2A

Stichwörter der Autor:innen

5-hydroxytryptamine (5-HT2A) receptorAlzheimer’s disease psychosis (ADP)mirtazapinepimavanserintrazodone

Substanzen

SerotoninReceptor, Serotonin, 5-HT2A

Autor:innen und Institutionen

  • Department of Rehabilitation, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China.
  • Department of Neurology, Liaocheng Veterans Hospital, China.
  • Department of Movement Sciences, Faculty of Medicine, Katholieke Universiteit Leuven, Belgium.

Zitieren

APA

Chen, Y., Sun, J., Yang, Z., & Bi, H. (2023). Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/161159

Vancouver

Chen Y, Sun J, Yang Z, Bi H. Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/161159

BibTeX
@article{Chen2023,
  author = {Chen, Yuxiao and Sun, Jie and Yang, Zhen and Bi, Hongyan},
  title = {Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2023},
  doi = {10.17219/acem/161159}
}
Kostenlos starten →